カテゴリー： QYResearch, 世界, 医療/バイオ

耳管機能不全治療のグローバル市場2023年：経口、外用

◆英語タイトル：Global Eustachian Tube Dysfunction Treatment Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA7463）◆商品コード：QYR23MA7463
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：86
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の耳管機能不全治療市場について調査・分析し、世界の耳管機能不全治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口、外用）、用途別セグメント分析（病院、診療所、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Novartis AG、Mylan N.V、Bristol-Myers Squibb、Pfizer Inc.、Bayer AG、Sanofi S.A.、Johnson & Johnson Services, Inc.、GlaxoSmithKline plc、Amgenなどが含まれています。世界の耳管機能不全治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、耳管機能不全治療市場規模を推定する際に考慮しました。

・耳管機能不全治療市場の概要
- 耳管機能不全治療のタイプ別セグメント
- 世界の耳管機能不全治療市場規模：タイプ別分析（経口、外用）
- 耳管機能不全治療の用途別セグメント
- 世界の耳管機能不全治療市場規模：用途別分析（病院、診療所、その他）
- 世界の耳管機能不全治療市場規模予測（2018年-2029年）

・耳管機能不全治療市場の成長トレンド
- 耳管機能不全治療の地域別市場規模（2018年-2029年）
- 耳管機能不全治療市場ダイナミクス
- 耳管機能不全治療の業界動向
- 耳管機能不全治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・タイプ別セグメント：経口、外用
- 世界の耳管機能不全治療のタイプ別市場規模（2018年-2023年）
- 世界の耳管機能不全治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、診療所、その他
- 世界の耳管機能不全治療の用途別市場規模（2018年-2023年）
- 世界の耳管機能不全治療の用途別市場規模（2024年-2029年）

・耳管機能不全治療の地域別市場規模
- 北米の耳管機能不全治療市場規模（2018年-2029年）
- アメリカの耳管機能不全治療市場規模（2018年-2029年）
- ヨーロッパの耳管機能不全治療市場規模（2018年-2029年）
- アジア太平洋の耳管機能不全治療市場規模（2018年-2029年）
- 中国の耳管機能不全治療市場規模（2018年-2029年）
- 日本の耳管機能不全治療市場規模（2018年-2029年）
- 韓国の耳管機能不全治療市場規模（2018年-2029年）
- インドの耳管機能不全治療市場規模（2018年-2029年）
- オーストラリアの耳管機能不全治療市場規模（2018年-2029年）
- 中南米の耳管機能不全治療市場規模（2018年-2029年）
- 中東・アフリカの耳管機能不全治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Novartis AG、Mylan N.V、Bristol-Myers Squibb、Pfizer Inc.、Bayer AG、Sanofi S.A.、Johnson & Johnson Services, Inc.、GlaxoSmithKline plc、Amgen

・アナリストの観点/結論

・調査方法とデータソース

Highlights
The global Eustachian Tube Dysfunction Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Eustachian Tube Dysfunction Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Eustachian Tube Dysfunction Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Eustachian Tube Dysfunction Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Eustachian Tube Dysfunction Treatment include Novartis AG, Mylan N.V, Bristol-Myers Squibb, Pfizer Inc., Bayer AG, Sanofi S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline plc and Amgen, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Eustachian Tube Dysfunction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eustachian Tube Dysfunction Treatment.
The Eustachian Tube Dysfunction Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Eustachian Tube Dysfunction Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Eustachian Tube Dysfunction Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Novartis AG
Mylan N.V
Bristol-Myers Squibb
Pfizer Inc.
Bayer AG
Sanofi S.A.
Johnson & Johnson Services, Inc.
GlaxoSmithKline plc
Amgen
Segment by Type
Oral
Topical
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Eustachian Tube Dysfunction Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eustachian Tube Dysfunction Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Topical
1.3 Market by Application
1.3.1 Global Eustachian Tube Dysfunction Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Eustachian Tube Dysfunction Treatment Market Perspective (2018-2029)
2.2 Eustachian Tube Dysfunction Treatment Growth Trends by Region
2.2.1 Global Eustachian Tube Dysfunction Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Eustachian Tube Dysfunction Treatment Historic Market Size by Region (2018-2023)
2.2.3 Eustachian Tube Dysfunction Treatment Forecasted Market Size by Region (2024-2029)
2.3 Eustachian Tube Dysfunction Treatment Market Dynamics
2.3.1 Eustachian Tube Dysfunction Treatment Industry Trends
2.3.2 Eustachian Tube Dysfunction Treatment Market Drivers
2.3.3 Eustachian Tube Dysfunction Treatment Market Challenges
2.3.4 Eustachian Tube Dysfunction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Eustachian Tube Dysfunction Treatment Players by Revenue
3.1.1 Global Top Eustachian Tube Dysfunction Treatment Players by Revenue (2018-2023)
3.1.2 Global Eustachian Tube Dysfunction Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Eustachian Tube Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Eustachian Tube Dysfunction Treatment Revenue
3.4 Global Eustachian Tube Dysfunction Treatment Market Concentration Ratio
3.4.1 Global Eustachian Tube Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Eustachian Tube Dysfunction Treatment Revenue in 2022
3.5 Eustachian Tube Dysfunction Treatment Key Players Head office and Area Served
3.6 Key Players Eustachian Tube Dysfunction Treatment Product Solution and Service
3.7 Date of Enter into Eustachian Tube Dysfunction Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Eustachian Tube Dysfunction Treatment Breakdown Data by Type
4.1 Global Eustachian Tube Dysfunction Treatment Historic Market Size by Type (2018-2023)
4.2 Global Eustachian Tube Dysfunction Treatment Forecasted Market Size by Type (2024-2029)
5 Eustachian Tube Dysfunction Treatment Breakdown Data by Application
5.1 Global Eustachian Tube Dysfunction Treatment Historic Market Size by Application (2018-2023)
5.2 Global Eustachian Tube Dysfunction Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Eustachian Tube Dysfunction Treatment Market Size (2018-2029)
6.2 North America Eustachian Tube Dysfunction Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Eustachian Tube Dysfunction Treatment Market Size by Country (2018-2023)
6.4 North America Eustachian Tube Dysfunction Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Eustachian Tube Dysfunction Treatment Market Size (2018-2029)
7.2 Europe Eustachian Tube Dysfunction Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Eustachian Tube Dysfunction Treatment Market Size by Country (2018-2023)
7.4 Europe Eustachian Tube Dysfunction Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Eustachian Tube Dysfunction Treatment Market Size (2018-2029)
8.2 Asia-Pacific Eustachian Tube Dysfunction Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Eustachian Tube Dysfunction Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Eustachian Tube Dysfunction Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Eustachian Tube Dysfunction Treatment Market Size (2018-2029)
9.2 Latin America Eustachian Tube Dysfunction Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Eustachian Tube Dysfunction Treatment Market Size by Country (2018-2023)
9.4 Latin America Eustachian Tube Dysfunction Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Eustachian Tube Dysfunction Treatment Market Size (2018-2029)
10.2 Middle East & Africa Eustachian Tube Dysfunction Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Eustachian Tube Dysfunction Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Eustachian Tube Dysfunction Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Eustachian Tube Dysfunction Treatment Introduction
11.1.4 Novartis AG Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.1.5 Novartis AG Recent Development
11.2 Mylan N.V
11.2.1 Mylan N.V Company Detail
11.2.2 Mylan N.V Business Overview
11.2.3 Mylan N.V Eustachian Tube Dysfunction Treatment Introduction
11.2.4 Mylan N.V Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.2.5 Mylan N.V Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Eustachian Tube Dysfunction Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Pfizer Inc.
11.4.1 Pfizer Inc. Company Detail
11.4.2 Pfizer Inc. Business Overview
11.4.3 Pfizer Inc. Eustachian Tube Dysfunction Treatment Introduction
11.4.4 Pfizer Inc. Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.4.5 Pfizer Inc. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Eustachian Tube Dysfunction Treatment Introduction
11.5.4 Bayer AG Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.5.5 Bayer AG Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Eustachian Tube Dysfunction Treatment Introduction
11.6.4 Sanofi S.A. Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.6.5 Sanofi S.A. Recent Development
11.7 Johnson & Johnson Services, Inc.
11.7.1 Johnson & Johnson Services, Inc. Company Detail
11.7.2 Johnson & Johnson Services, Inc. Business Overview
11.7.3 Johnson & Johnson Services, Inc. Eustachian Tube Dysfunction Treatment Introduction
11.7.4 Johnson & Johnson Services, Inc. Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.7.5 Johnson & Johnson Services, Inc. Recent Development
11.8 GlaxoSmithKline plc
11.8.1 GlaxoSmithKline plc Company Detail
11.8.2 GlaxoSmithKline plc Business Overview
11.8.3 GlaxoSmithKline plc Eustachian Tube Dysfunction Treatment Introduction
11.8.4 GlaxoSmithKline plc Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.8.5 GlaxoSmithKline plc Recent Development
11.9 Amgen
11.9.1 Amgen Company Detail
11.9.2 Amgen Business Overview
11.9.3 Amgen Eustachian Tube Dysfunction Treatment Introduction
11.9.4 Amgen Revenue in Eustachian Tube Dysfunction Treatment Business (2018-2023)
11.9.5 Amgen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 耳管機能不全治療のグローバル市場2023年：経口、外用(Global Eustachian Tube Dysfunction Treatment Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • マイボーム腺機能不全治療薬の世界市場見通し2023年-2029年
  • 世界の粘液線毛クリアランス＆機能不全治療市場インサイト及び予測（薬品、手術、粘液クリアランス装置、その他）
  • 世界の勃起不全真空収縮装置市場インサイト及び予測（手動、自動）
  • 世界の勃起不全（ED）装置市場インサイト及び予測（陰圧式勃起装置、ペニールプロテーゼ）
  • 世界の勃起不全ESWTユニット市場2022年：移動式、固定式